{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33744490",
  "DateCompleted": {
    "Year": "2021",
    "Month": "05",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "03",
        "Day": "09"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.coviro.2021.02.006",
      "S1879-6257(21)00016-X"
    ],
    "Journal": {
      "ISSN": "1879-6265",
      "JournalIssue": {
        "Volume": "47",
        "PubDate": {
          "Year": "2021",
          "Month": "Apr"
        }
      },
      "Title": "Current opinion in virology",
      "ISOAbbreviation": "Curr Opin Virol"
    },
    "ArticleTitle": "Coronavirus entry: how we arrived at SARS-CoV-2.",
    "Pagination": {
      "StartPage": "113",
      "EndPage": "120",
      "MedlinePgn": "113-120"
    },
    "Abstract": {
      "AbstractText": [
        "Because of the COVID-19 pandemic, the novel coronavirus SARS-CoV-2 has risen to shape scientific research during 2020, with its spike (S) protein being a predominant focus. The S protein is likely the most complicated of all viral glycoproteins and is a key factor in immunological responses and virus pathogenesis. It is also the driving force dictating virus entry mechanisms, which are highly 'plastic' for coronaviruses, allowing a plethora of options for different virus variants and strains in different cell types. Here we review coronavirus entry as a foundation for current work on SARS-CoV-2. We focus on the post-receptor binding events and cellular pathways that direct the membrane fusion events necessary for genome delivery, including S proteolytic priming and activation. We also address aspects of the entry process important for virus evolution and therapeutic development."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 The Author(s). Published by Elsevier B.V. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology and Master of Public Health Program, Cornell University, Ithaca, NY, USA. Electronic address: grw7@cornell.edu."
          }
        ],
        "LastName": "Whittaker",
        "ForeName": "Gary R",
        "Initials": "GR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Robert Frederick Smith School of Chemical & Biomolecular Engineering, Cornell University, Ithaca, NY, USA."
          }
        ],
        "LastName": "Daniel",
        "ForeName": "Susan",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Paris-Saclay, INRAE, UVSQ, Virologie et Immunologie Mol\u00e9culaires, Jouy-en-Josas, France."
          }
        ],
        "LastName": "Millet",
        "ForeName": "Jean K",
        "Initials": "JK"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 AI135270",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Curr Opin Virol",
    "NlmUniqueID": "101560941",
    "ISSNLinking": "1879-6257"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "etiology",
        "transmission"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Signal Transduction"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Virus Internalization"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}